Cladribine regimen for treating progressive forms of multiple sclerosis | Patent Number 10849919
US 10849919 B2Filled DateNov 23, 2018
Priority DateNov 24, 2017
Publication DateJun 6, 2019
Expiration DateNov 23, 2037
Inventor/ApplicantsMatthias Dotzauer
Fernando Dangond
Fernando Dangond
ExaminesULM, JOHN D
Art Unit1649
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.